Evidence map›Paper›PMID 19439978›Full record

ArticleInternational archives of allergy and immunology2009

NF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharide.

Guiming Li, Joanne Domenico, Yi Jia, Joseph J Lucas, Erwin W Gelfand

Open access · bronzeAbstract read
In one paragraph

Article in International archives of allergy and immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Mouse Bone Marrow Sca-1Infection and immunity · 2017
    Article
  17. Skin microbiome and mast cells.Translational research : the journal of laboratory and clinical medicine · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Guiming LiProgram in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA.
Joanne Domenico
Yi Jia
Joseph J Lucas
Erwin W Gelfand
University of Colorado Denver · US

Funding

NIAID NIH HHS HHSN266200400030CNIAID NIH HHS N01 AI040030
6 · The paper itself

Abstract

backgroundAn important aspect of the innate immune response to pathogens is the production of anti-microbial peptides such as cathelicidin-related antimicrobial peptide (CRAMP), the murine homologue of human cathelicidin LL-37. In this study, mechanisms regulating LPS-induction of CRAMP gene expression in mast cells were investigated. NF-kappaB and MAPK pathways were the focus of investigation.

methodsMouse bone marrow-derived mast cells were grown in culture and stimulated with LPS. MAPKs and NF-kappaB were monitored by immunoblot analysis. ERK, JNK and p38 MAPK were inhibited using siRNAs or a pharmacological inhibitor. Accumulation of the p65 component of NF-kappaB was inhibited by siRNA and NF-kappaB activation was inhibited by overexpression of I kappaB alpha. MEKK2 or MEKK3 were overexpressed by transfection. The effects of all of these treatments on CRAMP gene expression were monitored by RT-PCR.

resultsInhibition of ERK, JNK or p38 MAPK had little discernible effect on LPS-inducible CRAMP gene expression. Overexpression of MEKK2 or MEKK3 likewise had little impact. However, inhibition of the accumulation of p65 NF-kappaB prevented LPS-induced CRAMP mRNA. An important role for NF-kappaB in CRAMP gene expression was confirmed by overexpression of I kappaB alpha, which reduced both basal and induced levels of CRAMP mRNA.

conclusionsNF-kappaB, but not MAPKs, plays an important role in LPS-mediated induction of CRAMP gene in mast cells. Defects which inhibit NF-kappaB activity may increase susceptibility to bacterial and viral pathogens which are sensitive to cathelicidins.

Indexed as

AnimalsAntimicrobial Cationic PeptidesBone Marrow CellsCathelicidinsDose-Response Relationship, DrugGene ExpressionGene Expression RegulationI-kappa B ProteinsJNK Mitogen-Activated Protein KinasesLipopolysaccharidesMAP Kinase Kinase Kinase 2MAP Kinase Kinase Kinase 3Mast CellsMiceMice, Inbred BALB CMice, Inbred C57BLAntimicrobial Cationic PeptidesCathelicidinsI-kappa B ProteinsJNK Mitogen-Activated Protein KinasesLipopolysaccharidesMap3k2 protein, mouseMap3k3 protein, mouseMAP Kinase Kinase Kinase 2MAP Kinase Kinase Kinase 3Mitogen-Activated Protein KinasesNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanNfkbia protein, mousep38 Mitogen-Activated Protein KinasesRNA, Small InterferingTlr4 protein, mouseToll-Like Receptor 4Transcription Factor RelA

Identifiers

PMID19439978
PMCPMC2814151
OpenAlexW1969783259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.